Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 25 min 38 sec ago

New CyberKnife(R) and TomoTherapy(R) System Data Presented at Leading Scientific Industry Meeting

Mon, 11/02/2015 - 14:30
Excellent Treatment Outcomes for a Wide Range of Tumor Types Demonstrated by Accuray CyberKnife and TomoTherapy Systems SUNNYVALE, Calif., Nov. 2, 2015 -- (Healthcare Sales & Marketing Network) -- Accuray Incorporated (ARAY) announced today that studie...
Devices, Oncology
Accuray, CyberKnife, TomoTherapy

Shire to Acquire Dyax Corp, Expanding and Extending Industry-Leading Hereditary Angioedema (HAE) Portfolio

Mon, 11/02/2015 - 13:45
Lead pipeline product, DX-2930, is a Phase 3-ready asset, offering potentially transformative prophylactic therapy for HAE DUBLIN and BURLINGTON, Massachusetts, November 2, 2015 -- (Healthcare Sales & Marketing Network) --Shire plc (LSE: SHP, NASDAQ: S...
Biopharmaceuticals, Mergers & Acquisitions
Shire plc, Dyax, DX-2930, Hereditary Angioedema

PDI Enters Definitive Agreement to Sell Its Commercial Services Business to Publicis Healthcare Communications Group

Mon, 11/02/2015 - 13:12
PDI to Focus on Growing Molecular Diagnostics Business; Plans to Change Name to Interpace Diagnostics Group PDI to receive $25.5 to $32.5 million up front cash payment and a contingent earnout payment Combination Would Create A Global Leader in Healt...
Diagnostics, Acquisitions
PDI Inc, Publicis Healthcare Communications Group, Interpace Diagnostics Group

Regeneron Announces EU Approval of EYLEA(R) (aflibercept) Injection for the Treatment of Visual Impairment Secondary to Myopic Choroidal Neovascularization

Fri, 10/30/2015 - 21:57
TARRYTOWN, N.Y., Oct. 30, 2015 -- (Healthcare Sales & Marketing Network) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that Bayer HealthCare has received European approval for EYLEA® (aflibercept) Injection for the treatment of vis...
Biopharmaceuticals, Ophthalmology, Regulatory
Regeneron Pharmaceuticals, EYLEA, aflibercept

Mylan Appoints Ranjan Ray Chaudhuri as Global Commercial Lead for Mylan's Over-the-Counter Business

Fri, 10/30/2015 - 21:33
HERTFORDSHIRE, England and PITTSBURGH, Oct. 30, 2015 -- (Healthcare Sales & Marketing Network) -- Mylan N.V. (MYL), a leading global pharmaceutical company, today announced the appointment of Ranjan Ray Chaudhuri to serve as global commercial lead of the ...
Biopharmaceuticals, Personnel

Mallinckrodt's INOmax(R) Approved In Australia And Japan For Pulmonary Hypertension In Conjunction With Heart Surgery

Fri, 10/30/2015 - 17:52
Approved indication in Australia expanded to include use of INOmax for peri- and post-operative pulmonary hypertension in conjunction with cardiovascular surgery in infants and children up to age 17 Approved indication in Japan expanded to include use o...
Biopharmaceuticals, Regulatory
Mallinckrodt, INOmax, nitric oxide, pulmonary hypertension

Transcend Medical and Glaukos Corporation Settle Patent Litigation

Fri, 10/30/2015 - 13:57
MENLO PARK, CA--(Healthcare Sales & Marketing Network) - Transcend Medical, Inc. (“Transcend”) announced today that it has reached agreement with Glaukos Corporation (“Glaukos”) to settle the patent litigation pending between them in the U.S. District Cour...
Devices, Ophthalmology, Litigation
Transcend Medical, Glaukos, CyPass, Micro-Stent

Celgene’s VIDAZA(R) (Azacitidine for Injection) Approved by the European Commission as New Treatment for Elderly Patients with Acute Myeloid Leukaemia

Fri, 10/30/2015 - 13:50
Expanded indication brings medicine to greater number of elderly AML patients who are not eligible for haematopoietic stem cell transplantation and have >30% myeloblasts in their bone marrow BOUDRY, Switzerland--(Healthcare Sales & Marketing Network)...
Biopharmaceuticals, Oncology, Regulatory
Celgene, VIDAZA, azacitidine, acute myeloid leukaemia

Pfizer Announcement Regarding Allergan plc

Thu, 10/29/2015 - 15:37
Biopharmaceuticals, Mergers & Acquisitions
Pfizer, Allergan

Allergan plc Confirms Discussions Regarding Potential Business Combination Transaction With Pfizer Inc.

Thu, 10/29/2015 - 15:28
THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.4 OF IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 (THE "IRISH TAKEOVER RULES"). DUBLIN, Oct. 29, 2015 -- (Healthcare Sales & Marketing Network) -- Allergan plc today confirmed that it has b...
Biopharmaceuticals, Mergers & Acquisitions
Allergan, Pfizer

BioPharmX Corporation Names AnnaMarie Daniels Executive Vice President of Clinical and Regulatory Affairs

Thu, 10/29/2015 - 15:21
Life science veteran brings 30 years of experience managing development through commercialization of breakthrough dermatology, pharmaceutical and medical device products MENLO PARK, Calif., Oct. 29, 2015 -- (Healthcare Sales & Marketing Network) -- Bio...
Biopharmaceuticals, Dermatology, Personnel

CASMED Sells Vital Signs Monitoring Line, Tightens Focus on FORE-SIGHT Cerebral Oximetry Business

Thu, 10/29/2015 - 15:19
BRANFORD, Conn., Oct. 29, 2015 -- (Healthcare Sales & Marketing Network) -- CAS Medical Systems, Inc. (CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces the sale of assets related to its 740 SELECT(R) vital signs mo...
Devices, Monitoring, Neurosurgery, Acqusitions
CAS Medical Systems, CASMED, Zoe Medical, FORE-SIGHT, Cerebral Oximeter

Anika Appoints Richard Hague to Role of Chief Commercial Officer

Thu, 10/29/2015 - 15:14
Industry Veteran to Oversee Further Global Expansion of Commercial Platform, Strengthening of Commercial Partnerships, and Development of Direct Commercial Capability BEDFORD, Mass.--(Healthcare Sales & Marketing Network)--Anika Therapeutics, Inc., (ANI...
Devices, Orthopaedic, Personnel
Anika Therapeutics, hyaluronic acid, ORTHOVISC, MONOVISC

Bellicum Appoints Alan K. Smith as Senior Vice President of Manufacturing

Thu, 10/29/2015 - 15:08
HOUSTON--(Healthcare Sales & Marketing Network)--Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a clinical stage biopharmaceutical company focused on discovering and developing novel cellular immunotherapies, today announced the appointment of Alan K. Smith...
Biopharmaceuticals, Oncology, Personnel
Bellicum Pharmaceuticals, Chemical Induction of Dimerization

OrthoGrid(R) Systems, Inc. Announces the Launch of HipGrid DRONE(TM), a non-invasive Fluoroscopic Guide for Total Hip Replacement (THR)

Wed, 10/28/2015 - 15:24
OrthoGrid(R) Systems, Inc., Salt Lake City, Utah, has announced the release of the new HipGrid Drone(TM) for both anterior and posterior approach THR SALT LAKE CITY, Oct. 28, 2015 -- (Healthcare Sales & Marketing Network) -- Since the launch of HipGrid...
Devices, Orthopaedic, Product Launch
OrthoGrid Systems, HipGrid DRONE, Total Hip Replacement

InnFocus Inc. Names Randy Lindholm Executive Chairman of the Board

Wed, 10/28/2015 - 15:20
Mmove positions glaucoma company for domestic and international growth MIAMI, Oct. 28, 2015 -- (Healthcare Sales & Marketing Network) -- InnFocus, Inc. reports that Randy Lindholm has been named Executive Chairman of the Board of Directors. The Company...
Devices, Ophthalmology, Personnel
InnFocus, MicroShunt, glaucoma

Turnstone Biologics Completes Series A Financing Led by Versant Ventures, Strengthens Management Team

Wed, 10/28/2015 - 15:14
Investment accelerates robust clinical development of oncolytic viral immunotherapy pipeline TORONTO, Oct. 28, 2015 -- (Healthcare Sales & Marketing Network) - Turnstone Biologics Inc. ("Turnstone" or the "Company") announced the co...
Biopharmaceuticals, Oncology, Personnel, Venture Capital
Turnstone Biologics, oncolytic viral immunotherapy, immunotherapy

Personal Genome Diagnostics Secures $21.4 Million in Series A Financing Led By New Enterprise Associates

Wed, 10/28/2015 - 15:08
PGDx, a Leader in Cancer Genomic Analysis and Testing, Has Achieved Consistent Growth since Its Inception NEA Leads Funding Round with Support from Windham Venture Partners and Nanjing Kaiyuan Growth Capital Investments NEA Partner Justin Klein, MD, ...
Diagnostics, Oncology, Venture Capital, Personnel
Personal Genome Diagnostics, PGDx

Masimo Announces FDA 510(k) Clearance for MightySat(TM) Rx Fingertip Pulse Oximeter

Tue, 10/27/2015 - 15:54
IRVINE, Calif.--(Healthcare Sales & Marketing Network)--Masimo (MASI) announced today FDA 510(k) clearance for MightySat Rx, a fingertip pulse oximeter that incorporates Masimo SET® Measure-through Motion and Low Perfusion™ technology. MightySat Rx ...
Devices, Monitoring, FDA
Masimo, MightySat Rx, pulse oximeter, oxygen saturation

CoLucid Pharmaceuticals Announces Election of Mark Corrigan, M.D., to Board of Directors

Tue, 10/27/2015 - 15:51
CAMBRIDGE, Mass., Oct. 27, 2015 -- (Healthcare Sales & Marketing Network) -- CoLucid Pharmaceuticals, Inc. (CLCD), a Phase 3 clinical-stage biopharmaceutical company that is developing its lead product candidate, lasmiditan, for the acute treatment of migr...
Biopharmaceuticals, Neurology, Personnel
CoLucid Pharmaceuticals, lasmiditan, migraine

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong